Optimization of retinopathy of prematurity screening in a tertiary neonatal unit in Northern Greece based on 16-year data

Objective The optimal modification of retinopathy of prematurity (ROP) screening policy in our unit, by tightening the applicable screening criteria, without missing treatment-requiring ROP (TR-ROP). Study design Retrospective analysis of screened infants with gestational age (GA) 

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of perinatology 2022-03, Vol.42 (3), p.365-370
Hauptverfasser: Moutzouri, Stella, Haidich, Anna-Bettina, Seliniotaki, Aikaterini K., Tsakalidis, Christos, Soubasi, Vasiliki, Ziakas, Nikolaos, Mataftsi, Asimina
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 370
container_issue 3
container_start_page 365
container_title Journal of perinatology
container_volume 42
creator Moutzouri, Stella
Haidich, Anna-Bettina
Seliniotaki, Aikaterini K.
Tsakalidis, Christos
Soubasi, Vasiliki
Ziakas, Nikolaos
Mataftsi, Asimina
description Objective The optimal modification of retinopathy of prematurity (ROP) screening policy in our unit, by tightening the applicable screening criteria, without missing treatment-requiring ROP (TR-ROP). Study design Retrospective analysis of screened infants with gestational age (GA) 
doi_str_mv 10.1038/s41372-021-01196-2
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2568596896</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2637813076</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-87d55427b53b5baf2580a30ddbb6c33f0e5fae41e3e60d44c073afb7545ed4f93</originalsourceid><addsrcrecordid>eNp9kT9v1TAUxS0Eoq8tX4ABWWJhMbV9_SdvRBUUpKpd6Gw5yU3r6sUJtjOknx6HV0BiYLKs8zvH9_oQ8lbwj4JDc5GVACsZl4JxIfaGyRdkJ5Q1TGsFL8mOWwWsAWVOyGnOj5xvon1NTkApK6QwO7LeziWM4cmXMEU6DTRhCXGafXlYt-uccPRlSaGsNHcJMYZ4T0OknhZMJfi00ohT9MUf6BJD2bSbKZUHTJFeVUOHtPUZe1rzhWEr-kT7ip-TV4M_ZHzzfJ6Ruy-fv19-Zde3V98uP12zDqwurLF93UbaVkOrWz9I3XAPvO_b1nQAA0c9eFQCAQ3vleq4BT-0ViuNvRr2cEY-HHPnNP1YMBc3htzh4eDr3Et2UptG702zNxV9_w_6OC0p1umcNGAbAdxulDxSXZpyTji4OYWxfoQT3G3FuGMxrhbjfhXjZDW9e45e2hH7P5bfTVQAjkCuUrzH9Pft_8T-BGu_meg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2637813076</pqid></control><display><type>article</type><title>Optimization of retinopathy of prematurity screening in a tertiary neonatal unit in Northern Greece based on 16-year data</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Moutzouri, Stella ; Haidich, Anna-Bettina ; Seliniotaki, Aikaterini K. ; Tsakalidis, Christos ; Soubasi, Vasiliki ; Ziakas, Nikolaos ; Mataftsi, Asimina</creator><creatorcontrib>Moutzouri, Stella ; Haidich, Anna-Bettina ; Seliniotaki, Aikaterini K. ; Tsakalidis, Christos ; Soubasi, Vasiliki ; Ziakas, Nikolaos ; Mataftsi, Asimina</creatorcontrib><description><![CDATA[Objective The optimal modification of retinopathy of prematurity (ROP) screening policy in our unit, by tightening the applicable screening criteria, without missing treatment-requiring ROP (TR-ROP). Study design Retrospective analysis of screened infants with gestational age (GA) < 32 weeks and/or birth weight (BW) < 1501 g as well as cases beyond these thresholds but with comorbidities (April 2004 to April 2020). Result Of 1560 included infants, 18.4% ( n  = 288) developed any stage of ROP and 3.1% ( n  = 49) were treated. TR-ROP occurred at a mean (SD) 36 2/7 (2 5/7 ) weeks PMA, and not before a minimum of 32 3/7 weeks PMA. No treated infant would have been missed if screening criteria were reduced to GA < 30 weeks and/or BW < 1251 g. This modification would have resulted in 826 (52.9%) fewer infants undergoing screening. Conclusion Modifying the current screening criteria to GA < 30 weeks and/or BW < 1251 g would have spared over half of the screened infants from unnecessary examinations, without missing TR-ROP.]]></description><identifier>ISSN: 0743-8346</identifier><identifier>EISSN: 1476-5543</identifier><identifier>DOI: 10.1038/s41372-021-01196-2</identifier><identifier>PMID: 34471216</identifier><language>eng</language><publisher>New York: Nature Publishing Group US</publisher><subject>692/308/174 ; 692/700/1538 ; Birth Weight ; Criteria ; Gestational Age ; Greece - epidemiology ; Health sciences ; Hospitals ; Humans ; Incidence ; Infant ; Infant, Newborn ; Infant, Premature ; Infants ; Intensive care ; Investigations ; Medicine ; Medicine &amp; Public Health ; Neonatal care ; Neonatal Screening - methods ; Neonates ; Newborn babies ; Optimization ; Pediatric Surgery ; Pediatrics ; Premature babies ; Premature birth ; Preventive medicine ; Regression analysis ; Retinopathy ; Retinopathy of Prematurity - diagnosis ; Retinopathy of Prematurity - epidemiology ; Retinopathy of Prematurity - therapy ; Retrospective Studies ; Risk Factors ; Screening ; Workloads</subject><ispartof>Journal of perinatology, 2022-03, Vol.42 (3), p.365-370</ispartof><rights>The Author(s), under exclusive licence to Springer Nature America, Inc. 2021</rights><rights>2021. The Author(s), under exclusive licence to Springer Nature America, Inc.</rights><rights>The Author(s), under exclusive licence to Springer Nature America, Inc. 2021.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-87d55427b53b5baf2580a30ddbb6c33f0e5fae41e3e60d44c073afb7545ed4f93</citedby><cites>FETCH-LOGICAL-c375t-87d55427b53b5baf2580a30ddbb6c33f0e5fae41e3e60d44c073afb7545ed4f93</cites><orcidid>0000-0002-4238-022X ; 0000-0002-2585-2133</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/s41372-021-01196-2$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/s41372-021-01196-2$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27923,27924,41487,42556,51318</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34471216$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Moutzouri, Stella</creatorcontrib><creatorcontrib>Haidich, Anna-Bettina</creatorcontrib><creatorcontrib>Seliniotaki, Aikaterini K.</creatorcontrib><creatorcontrib>Tsakalidis, Christos</creatorcontrib><creatorcontrib>Soubasi, Vasiliki</creatorcontrib><creatorcontrib>Ziakas, Nikolaos</creatorcontrib><creatorcontrib>Mataftsi, Asimina</creatorcontrib><title>Optimization of retinopathy of prematurity screening in a tertiary neonatal unit in Northern Greece based on 16-year data</title><title>Journal of perinatology</title><addtitle>J Perinatol</addtitle><addtitle>J Perinatol</addtitle><description><![CDATA[Objective The optimal modification of retinopathy of prematurity (ROP) screening policy in our unit, by tightening the applicable screening criteria, without missing treatment-requiring ROP (TR-ROP). Study design Retrospective analysis of screened infants with gestational age (GA) < 32 weeks and/or birth weight (BW) < 1501 g as well as cases beyond these thresholds but with comorbidities (April 2004 to April 2020). Result Of 1560 included infants, 18.4% ( n  = 288) developed any stage of ROP and 3.1% ( n  = 49) were treated. TR-ROP occurred at a mean (SD) 36 2/7 (2 5/7 ) weeks PMA, and not before a minimum of 32 3/7 weeks PMA. No treated infant would have been missed if screening criteria were reduced to GA < 30 weeks and/or BW < 1251 g. This modification would have resulted in 826 (52.9%) fewer infants undergoing screening. Conclusion Modifying the current screening criteria to GA < 30 weeks and/or BW < 1251 g would have spared over half of the screened infants from unnecessary examinations, without missing TR-ROP.]]></description><subject>692/308/174</subject><subject>692/700/1538</subject><subject>Birth Weight</subject><subject>Criteria</subject><subject>Gestational Age</subject><subject>Greece - epidemiology</subject><subject>Health sciences</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Incidence</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>Infant, Premature</subject><subject>Infants</subject><subject>Intensive care</subject><subject>Investigations</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Neonatal care</subject><subject>Neonatal Screening - methods</subject><subject>Neonates</subject><subject>Newborn babies</subject><subject>Optimization</subject><subject>Pediatric Surgery</subject><subject>Pediatrics</subject><subject>Premature babies</subject><subject>Premature birth</subject><subject>Preventive medicine</subject><subject>Regression analysis</subject><subject>Retinopathy</subject><subject>Retinopathy of Prematurity - diagnosis</subject><subject>Retinopathy of Prematurity - epidemiology</subject><subject>Retinopathy of Prematurity - therapy</subject><subject>Retrospective Studies</subject><subject>Risk Factors</subject><subject>Screening</subject><subject>Workloads</subject><issn>0743-8346</issn><issn>1476-5543</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kT9v1TAUxS0Eoq8tX4ABWWJhMbV9_SdvRBUUpKpd6Gw5yU3r6sUJtjOknx6HV0BiYLKs8zvH9_oQ8lbwj4JDc5GVACsZl4JxIfaGyRdkJ5Q1TGsFL8mOWwWsAWVOyGnOj5xvon1NTkApK6QwO7LeziWM4cmXMEU6DTRhCXGafXlYt-uccPRlSaGsNHcJMYZ4T0OknhZMJfi00ohT9MUf6BJD2bSbKZUHTJFeVUOHtPUZe1rzhWEr-kT7ip-TV4M_ZHzzfJ6Ruy-fv19-Zde3V98uP12zDqwurLF93UbaVkOrWz9I3XAPvO_b1nQAA0c9eFQCAQ3vleq4BT-0ViuNvRr2cEY-HHPnNP1YMBc3htzh4eDr3Et2UptG702zNxV9_w_6OC0p1umcNGAbAdxulDxSXZpyTji4OYWxfoQT3G3FuGMxrhbjfhXjZDW9e45e2hH7P5bfTVQAjkCuUrzH9Pft_8T-BGu_meg</recordid><startdate>20220301</startdate><enddate>20220301</enddate><creator>Moutzouri, Stella</creator><creator>Haidich, Anna-Bettina</creator><creator>Seliniotaki, Aikaterini K.</creator><creator>Tsakalidis, Christos</creator><creator>Soubasi, Vasiliki</creator><creator>Ziakas, Nikolaos</creator><creator>Mataftsi, Asimina</creator><general>Nature Publishing Group US</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7RV</scope><scope>7T5</scope><scope>7T7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-4238-022X</orcidid><orcidid>https://orcid.org/0000-0002-2585-2133</orcidid></search><sort><creationdate>20220301</creationdate><title>Optimization of retinopathy of prematurity screening in a tertiary neonatal unit in Northern Greece based on 16-year data</title><author>Moutzouri, Stella ; Haidich, Anna-Bettina ; Seliniotaki, Aikaterini K. ; Tsakalidis, Christos ; Soubasi, Vasiliki ; Ziakas, Nikolaos ; Mataftsi, Asimina</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-87d55427b53b5baf2580a30ddbb6c33f0e5fae41e3e60d44c073afb7545ed4f93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>692/308/174</topic><topic>692/700/1538</topic><topic>Birth Weight</topic><topic>Criteria</topic><topic>Gestational Age</topic><topic>Greece - epidemiology</topic><topic>Health sciences</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Incidence</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>Infant, Premature</topic><topic>Infants</topic><topic>Intensive care</topic><topic>Investigations</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Neonatal care</topic><topic>Neonatal Screening - methods</topic><topic>Neonates</topic><topic>Newborn babies</topic><topic>Optimization</topic><topic>Pediatric Surgery</topic><topic>Pediatrics</topic><topic>Premature babies</topic><topic>Premature birth</topic><topic>Preventive medicine</topic><topic>Regression analysis</topic><topic>Retinopathy</topic><topic>Retinopathy of Prematurity - diagnosis</topic><topic>Retinopathy of Prematurity - epidemiology</topic><topic>Retinopathy of Prematurity - therapy</topic><topic>Retrospective Studies</topic><topic>Risk Factors</topic><topic>Screening</topic><topic>Workloads</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Moutzouri, Stella</creatorcontrib><creatorcontrib>Haidich, Anna-Bettina</creatorcontrib><creatorcontrib>Seliniotaki, Aikaterini K.</creatorcontrib><creatorcontrib>Tsakalidis, Christos</creatorcontrib><creatorcontrib>Soubasi, Vasiliki</creatorcontrib><creatorcontrib>Ziakas, Nikolaos</creatorcontrib><creatorcontrib>Mataftsi, Asimina</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of perinatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Moutzouri, Stella</au><au>Haidich, Anna-Bettina</au><au>Seliniotaki, Aikaterini K.</au><au>Tsakalidis, Christos</au><au>Soubasi, Vasiliki</au><au>Ziakas, Nikolaos</au><au>Mataftsi, Asimina</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Optimization of retinopathy of prematurity screening in a tertiary neonatal unit in Northern Greece based on 16-year data</atitle><jtitle>Journal of perinatology</jtitle><stitle>J Perinatol</stitle><addtitle>J Perinatol</addtitle><date>2022-03-01</date><risdate>2022</risdate><volume>42</volume><issue>3</issue><spage>365</spage><epage>370</epage><pages>365-370</pages><issn>0743-8346</issn><eissn>1476-5543</eissn><abstract><![CDATA[Objective The optimal modification of retinopathy of prematurity (ROP) screening policy in our unit, by tightening the applicable screening criteria, without missing treatment-requiring ROP (TR-ROP). Study design Retrospective analysis of screened infants with gestational age (GA) < 32 weeks and/or birth weight (BW) < 1501 g as well as cases beyond these thresholds but with comorbidities (April 2004 to April 2020). Result Of 1560 included infants, 18.4% ( n  = 288) developed any stage of ROP and 3.1% ( n  = 49) were treated. TR-ROP occurred at a mean (SD) 36 2/7 (2 5/7 ) weeks PMA, and not before a minimum of 32 3/7 weeks PMA. No treated infant would have been missed if screening criteria were reduced to GA < 30 weeks and/or BW < 1251 g. This modification would have resulted in 826 (52.9%) fewer infants undergoing screening. Conclusion Modifying the current screening criteria to GA < 30 weeks and/or BW < 1251 g would have spared over half of the screened infants from unnecessary examinations, without missing TR-ROP.]]></abstract><cop>New York</cop><pub>Nature Publishing Group US</pub><pmid>34471216</pmid><doi>10.1038/s41372-021-01196-2</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-4238-022X</orcidid><orcidid>https://orcid.org/0000-0002-2585-2133</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0743-8346
ispartof Journal of perinatology, 2022-03, Vol.42 (3), p.365-370
issn 0743-8346
1476-5543
language eng
recordid cdi_proquest_miscellaneous_2568596896
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects 692/308/174
692/700/1538
Birth Weight
Criteria
Gestational Age
Greece - epidemiology
Health sciences
Hospitals
Humans
Incidence
Infant
Infant, Newborn
Infant, Premature
Infants
Intensive care
Investigations
Medicine
Medicine & Public Health
Neonatal care
Neonatal Screening - methods
Neonates
Newborn babies
Optimization
Pediatric Surgery
Pediatrics
Premature babies
Premature birth
Preventive medicine
Regression analysis
Retinopathy
Retinopathy of Prematurity - diagnosis
Retinopathy of Prematurity - epidemiology
Retinopathy of Prematurity - therapy
Retrospective Studies
Risk Factors
Screening
Workloads
title Optimization of retinopathy of prematurity screening in a tertiary neonatal unit in Northern Greece based on 16-year data
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T12%3A07%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Optimization%20of%20retinopathy%20of%20prematurity%20screening%20in%20a%20tertiary%20neonatal%20unit%20in%20Northern%20Greece%20based%20on%2016-year%20data&rft.jtitle=Journal%20of%20perinatology&rft.au=Moutzouri,%20Stella&rft.date=2022-03-01&rft.volume=42&rft.issue=3&rft.spage=365&rft.epage=370&rft.pages=365-370&rft.issn=0743-8346&rft.eissn=1476-5543&rft_id=info:doi/10.1038/s41372-021-01196-2&rft_dat=%3Cproquest_cross%3E2637813076%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2637813076&rft_id=info:pmid/34471216&rfr_iscdi=true